AustralianSuper Pty Ltd Has $155.58 Million Holdings in Mettler-Toledo International, Inc. $MTD

AustralianSuper Pty Ltd raised its holdings in Mettler-Toledo International, Inc. (NYSE:MTDFree Report) by 7.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 126,734 shares of the medical instruments supplier’s stock after acquiring an additional 8,333 shares during the period. Mettler-Toledo International comprises 0.7% of AustralianSuper Pty Ltd’s holdings, making the stock its 27th biggest holding. AustralianSuper Pty Ltd owned approximately 0.62% of Mettler-Toledo International worth $155,580,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in MTD. Vanguard Group Inc. increased its holdings in Mettler-Toledo International by 0.5% in the 2nd quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier’s stock worth $3,003,415,000 after purchasing an additional 13,342 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock valued at $1,062,257,000 after buying an additional 376,419 shares during the period. Alliancebernstein L.P. increased its stake in shares of Mettler-Toledo International by 1.1% in the second quarter. Alliancebernstein L.P. now owns 717,449 shares of the medical instruments supplier’s stock valued at $842,802,000 after buying an additional 8,121 shares during the period. Geode Capital Management LLC raised its holdings in Mettler-Toledo International by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock valued at $681,489,000 after buying an additional 3,383 shares during the last quarter. Finally, Fiera Capital Corp boosted its position in Mettler-Toledo International by 19.0% during the 2nd quarter. Fiera Capital Corp now owns 342,837 shares of the medical instruments supplier’s stock worth $402,737,000 after buying an additional 54,740 shares during the period. Institutional investors own 95.07% of the company’s stock.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, CEO Patrick Kaltenbach sold 2,000 shares of the business’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the transaction, the chief executive officer directly owned 3,670 shares in the company, valued at $5,367,375. The trade was a 35.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gerry Keller sold 236 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total transaction of $334,784.88. Following the sale, the insider owned 159 shares of the company’s stock, valued at approximately $225,554.22. The trade was a 59.75% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 19,565 shares of company stock worth $28,683,737. Company insiders own 0.77% of the company’s stock.

Mettler-Toledo International Price Performance

MTD stock opened at $1,400.86 on Thursday. The company’s 50-day moving average is $1,434.10 and its 200-day moving average is $1,350.38. The stock has a market capitalization of $28.62 billion, a PE ratio of 34.93, a price-to-earnings-growth ratio of 4.24 and a beta of 1.41. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The business had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. During the same quarter last year, the firm posted $10.21 EPS. Mettler-Toledo International’s revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MTD has been the subject of several recent research reports. Morgan Stanley assumed coverage on shares of Mettler-Toledo International in a research report on Tuesday, December 2nd. They issued an “equal weight” rating and a $1,550.00 price target for the company. Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective for the company in a report on Monday, December 15th. Citigroup raised their target price on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. The Goldman Sachs Group started coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 target price on the stock. Finally, Stifel Nicolaus increased their price target on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and a consensus price target of $1,441.67.

Check Out Our Latest Report on MTD

About Mettler-Toledo International

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Further Reading

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.